Table 2.
HR (95% CI) | P Value | |
---|---|---|
Heart rate by 10/min | 1.079 (1.035 to 1.124) | 0.0003 |
Age ≥75 years | 1.461 (1.258 to 1.697) | <0.0001 |
Multirace | 1.417 (1.081 to 1.857) | 0.0115 |
Region: North America | 1.298 (1.144 to 1.473) | <0.0001 |
History of hypertension | 1.156 (1.012 to 1.321) | 0.0323 |
History of diabetes mellitus | 1.378 (1.228 to 1.546) | <0.0001 |
History of stroke | 1.266 (1.023 to 1.568) | 0.0302 |
History of myocardial infarction | 1.377 (1.201 to 1.580) | <0.0001 |
History of peripheral arterial vascular disease | 1.595 (1.359 to 1.872) | <0.0001 |
History of percutaneous coronary intervention | 1.160 (1.012 to 1.330) | 0.0334 |
History of coronary artery bypass grafting | 1.713 (1.479 to 1.983) | <0.0001 |
Qualifying event: troponin or CK‐MB >upper limit of normal | 1.670 (1.254 to 2.224) | 0.0004 |
ST‐segment elevation at enrollment | 1.254 (0.991 to 1.587) | 0.0598 |
ST‐segment depression at enrollment | 1.384 (1.232 to 1.556) | <0.0001 |
Renal insufficiency: CrCl <30 mL/min | 2.459 (1.818 to 3.325) | <0.0001 |
Renal insufficiency: CrCl ≤30 to <60 mL/min | 1.382 (1.174 to 1.627) | 0.0001 |
Killip scale I | 0.600 (0.500 to 0.722) | <0.0001 |
Taking thienopyridine at enrollment | 1.191 (1.000 to 1.419) | 0.0505 |
Taking statin at enrollment | 1.193 (1.027 to 1.384) | 0.0206 |
CI indicates confidence interval; CK‐MB, creatine kinase‐MB; CrCl, creatinine clearance; CVD, cardiovascular death; HR, hazard ratio; MI, myocardial infarction.